MyAverix Finance
NS · Pharmaceuticals
Bafna Pharmaceuticals Ltd (BAFNAPH)
Pharmaceuticals & Biotechnology
Bafna Pharmaceuticals Ltd (BAFNAPH) is listed on NS in the Pharmaceuticals sector. Industry: Pharmaceuticals & Biotechnology. As of 2026-07-10, reported market cap is $4.18B, P/E ratio is 37.65, net margin is 4.9%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for BAFNAPH
Bafna Pharmaceuticals Ltd (BAFNAPH) — FAQ
What is Bafna Pharmaceuticals Ltd's market cap?
Bafna Pharmaceuticals Ltd (BAFNAPH) has a reported market cap of $4.18B (data as of 2026-07-10).
What is BAFNAPH's P/E ratio?
The price-to-earnings (P/E) ratio for Bafna Pharmaceuticals Ltd (BAFNAPH) is 37.65 (data as of 2026-07-10).
Does Bafna Pharmaceuticals Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Bafna Pharmaceuticals Ltd (BAFNAPH). Check the MyAverix Finance app for the latest dividend data.
What sector is Bafna Pharmaceuticals Ltd in?
Bafna Pharmaceuticals Ltd (BAFNAPH) is classified in the Pharmaceuticals sector (Pharmaceuticals & Biotechnology industry).
What exchange is BAFNAPH listed on?
BAFNAPH is listed on NS.
What is Bafna Pharmaceuticals Ltd's net margin?
Bafna Pharmaceuticals Ltd (BAFNAPH) reports a net margin of 4.9% (data as of 2026-07-10).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.